MedTrace Logo

Transnasal Humidified Rapid Insufflation System for Intubation

NCT04238351 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-02-18

No results posted yet for this study

Summary

Transnasal humidified rapid insufflation ventilator exchange (THRIVE) or not during the anesthesia induction

Conditions

  • Hypoxemia

Interventions

DEVICE

Transnasal humidified rapid insufflation ventilator exchange

applying 40L of oxygen for 1min and afte that increase oxygen flow up to 70L for 1 min.

DEVICE

Conventional face mask

applying oxygen using usual face mask

Sponsors & Collaborators

  • Gachon University Gil Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-25
Primary Completion
2020-11-30
Completion
2020-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04238351 on ClinicalTrials.gov